Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 5
119
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Sugammadex versus neostigmine for routine reversal of neuromuscular blockade and the effect on perioperative efficiency

, MDORCID Icon, , MD, , PhD & , MD
Pages 599-603 | Received 18 Mar 2022, Accepted 09 May 2022, Published online: 06 Jun 2022

  • Merck. How are you dosing BRIDION? 2022. https://www.merckconnect.com/static/pdf/bridion-sugammadex-dosing-considerations.pdf.
  • Van Pelt M, Chitilian HV, Eikerman M. Multi-faceted initiative designed to improve safety of neuromuscular blockade. APSF News. 2016;3(3):51–52. https://www.apsf.org/wp-content/uploads/newsletters/2016/February/pdf/APSF201602.pdf
  • Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. doi:10.1080/00273171.2011.568786.
  • Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111(1):120–128. doi:10.1213/ANE.0b013e3181da832d.
  • Hristovska AM, Duch P, Allingstrup M, Afshari A. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database Syst Rev. 2017;8(8):CD012763. doi:10.1002/14651858.CD012763.
  • Nair VP, Hunter JM. Anticholinesterases and anticholinergic drugs. Crit Care Pain. 2004;4:164–168.
  • Paton F, Paulden M, Chambers D, et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth. 2010;105(5):558–567. doi:10.1093/bja/aeq269.
  • Zaouter C, Mion S, Palomba A, Hemmerling T. A short update on sugammadex with a special focus on economic assessment of its use in North America. J Anesth Clin Res. 2017;08(07):740. doi:10.4172/2155-6148.1000740.
  • Hurford WE, Welge JA, Eckman MH. Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: a cost analysis. J Clin Anesth. 2020;67:110027. doi:10.1016/j.jclinane.2020.110027.
  • Deyhim N, Beck A, Balk J, Liebl MG. Impact of sugammadex versus neostigmine/glycopyrrolate on perioperative efficiency. CEOR. 2020;12:69–79. doi:10.2147/CEOR.S221308.
  • Koo B, Oh A, Na H, et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia. 2018;73(9):1090–1096. doi:10.1111/anae.14304.
  • Carron M, Baratto F, Zarantonello F, Ori C. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center. CEOR. 2016;8:43–52. doi:10.2147/CEOR.S100921.
  • Min BH, Oh TK, Song IA, Jeon YT. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study. BMC Anesthesiol. 2020;20(1):178. doi:10.1186/s12871-020-01088-6.
  • Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Eur J Anaesthesiol. 2014;31(8):423–429. doi:10.1097/EJA.0000000000000010.
  • Ledowski T, Hillyard S, Kozman A, et al. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intens Care. 2012;40(2):340–343. doi:10.1177/0310057X1204000219.
  • Abad-Gurumeta A, Ripollés-Melchor J, Casans-Francés R, et al; Evidence Anaesthesia Review Group. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia. 2015;70(12):1441–1452. doi:10.1111/anae.13277.
  • Butterly A, Bittner E, George E, Sandberg W, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105(3):304–309. doi:10.1093/bja/aeq157.
  • Li G, Freundlich RE, Gupta RK, et al. Postoperative pulmonary complications' association with sugammadex versus neostigmine: a retrospective registry analysis. Anesthesiology. 2021;134(6):862–873. doi:10.1097/ALN.0000000000003735.
  • Girotto JA, Koltz PF, Drugas G. Optimizing your operating room: or, why large, traditional hospitals don't work. Int J Surg. 2010;8(5):359–367. doi:10.1016/j.ijsu.2010.05.002.
  • Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153(4):e176233–e176233. doi:10.1001/jamasurg.2017.6233.
  • Thilen SR, Weigel WA. Sugammadex: a costly simple solution that is not really solving the problem. Anesth Analg. 2020;131(2):e73–e74. doi:10.1213/ANE.0000000000004761.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.